Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP474432.RAvDXoo9bT5adKDpfQHADsyY9-5IhSaS3bntfzqhlnYd0130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP474432.RAvDXoo9bT5adKDpfQHADsyY9-5IhSaS3bntfzqhlnYd0130_assertion type Assertion NP474432.RAvDXoo9bT5adKDpfQHADsyY9-5IhSaS3bntfzqhlnYd0130_head.
- NP474432.RAvDXoo9bT5adKDpfQHADsyY9-5IhSaS3bntfzqhlnYd0130_assertion description "[Mkk4 immunolabeling patterns were also evaluated among unresectable primary and metastatic cancer tissues from autopsy specimens, indicating intact Mkk4 immunolabeling in 88.8% of the unresectable primary carcinomas as compared with 63.3% of distant metastases (P < 0.001).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP474432.RAvDXoo9bT5adKDpfQHADsyY9-5IhSaS3bntfzqhlnYd0130_provenance.
- NP474432.RAvDXoo9bT5adKDpfQHADsyY9-5IhSaS3bntfzqhlnYd0130_assertion evidence source_evidence_literature NP474432.RAvDXoo9bT5adKDpfQHADsyY9-5IhSaS3bntfzqhlnYd0130_provenance.
- NP474432.RAvDXoo9bT5adKDpfQHADsyY9-5IhSaS3bntfzqhlnYd0130_assertion SIO_000772 15623633 NP474432.RAvDXoo9bT5adKDpfQHADsyY9-5IhSaS3bntfzqhlnYd0130_provenance.
- NP474432.RAvDXoo9bT5adKDpfQHADsyY9-5IhSaS3bntfzqhlnYd0130_assertion wasDerivedFrom befree-2016 NP474432.RAvDXoo9bT5adKDpfQHADsyY9-5IhSaS3bntfzqhlnYd0130_provenance.
- NP474432.RAvDXoo9bT5adKDpfQHADsyY9-5IhSaS3bntfzqhlnYd0130_assertion wasGeneratedBy ECO_0000203 NP474432.RAvDXoo9bT5adKDpfQHADsyY9-5IhSaS3bntfzqhlnYd0130_provenance.